Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Oligodendrogenesis and oligodendrocyte precursor maturation are essential processes during the course of central nervous system development, and lead to the myelination of axons. Cells of the oligodendrocyte lineage are generated in the germinal zone from migratory bipolar oligodendrocyte precursor cells (OPCs), and acquire cell surface markers as they mature and respond specifically to factors which regulate proliferation, migration, differentiation, and survival. Loss of myelin underlies a wide range of neurological disorders, some of an autoimmune nature-multiple sclerosis probably being the most prominent. Current therapies are based on the use of immunomodulatory agents which are likely to promote myelin repair (remyelination) indirectly by subverting the inflammatory response, aspects of which impair the differentiation of OPCs. Cells of the oligodendrocyte lineage express and are capable of responding to a diverse array of ligand-receptor pairs, including neurotransmitters and nuclear receptors such as γ-aminobutyric acid, glutamate, adenosine triphosphate, serotonin, acetylcholine, nitric oxide, opioids, prostaglandins, prolactin, and cannabinoids. The intent of this review is to provide the reader with a synopsis of our present state of knowledge concerning the pharmacological properties of the oligodendrocyte lineage, with particular attention to these receptor-ligand (i.e., neurotransmitters and nuclear receptor) interactions that can influence oligodendrocyte migration, proliferation, differentiation, and myelination, and an appraisal of their therapeutic potential. For example, many promising mediators work through Ca(2+) signaling, and the balance between Ca(2+) influx and efflux can determine the temporal and spatial properties of oligodendrocytes (OLs). Moreover, Ca(2+) signaling in OPCs can influence not only differentiation and myelination, but also process extension and migration, as well as cell death in mature mouse OLs. There is also evidence that oligodendroglia exhibit Ca(2+) transients in response to electrical activity of axons for activity-dependent myelination. Cholinergic antagonists, as well as endocannabinoid-related lipid-signaling molecules target OLs. An understanding of such pharmacological pathways may thus lay the foundation to allow its leverage for therapeutic benefit in diseases of demyelination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tracey, K. J. (2002) · Nature · doi:10.1038/nature01321 · Cited by 3,728 · cited 2×
“, 2009), nicotinic cholinergic receptors affect inflammation centrally by modulating microglial release of cytokines, and peripherally through immune system cells (Tracey, 2002; De Simone et al., 2005; Kawashima and Fuji, 2008).”
BackgroundDopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
The Glutamate Receptor Ion Channels
Dingledine, R., Borges, K., Bowie, D., & Traynelis, S. F. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01394-2 · Cited by 3,554 · cited 2×
“The former comprise the ligand-gated ion channel N-methyl-D-aspartate (NMDA), alpha-amino3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and kainate receptor subtypes (Dingledine et al., 1999; Swanson et al., 2005).”
BackgroundInterneurons of the neocortical inhibitory system
Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., & Wu, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1519 · Cited by 2,954 · cited 2×
“GABAergic Signals GABA is the main inhibitory neurotransmitter in adult brain (Koós and Tepper, 1999; Markram et al., 2004; Takesian and Hensch, 2013), where it binds two main receptor types: fast hyperpolarizing ionotropic GABAA receptors and metabotropic GABAB receptors.”
BackgroundMolecular Physiology of P2X Receptors
North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919 · cited 2×
“Purinergic Signals ATP is a co-transmitter released with other ‘‘classical’’ transmitters and activates ionotropic (P2X) and metabotropic (P2Y) receptors (Ralevic and Burnstock, 1998; North, 2002).”
BackgroundInternational Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Prolactin: structure, function, and regulation of secretion
Freeman, M. E., Kanyicska, B., Lerant, A., & Nagy, G. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1523 · Cited by 2,457 · cited 2×
“Therefore, anti-oxidant and mitochondria protective therapeutic strategies may be beneficial in MS, in particular in early stages of the disease (Lassmann, 2011).”
BackgroundPhysiological and Molecular Basis of Thyroid Hormone Action
Yen, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1097 · Cited by 2,011 · cited 4×
“Thyroid Hormone TH actions are mediated mainly by T3 (Yen, 2001) which derives by conversion of T4 to T3 via deiodinases.”
BackgroundInfluentialRemyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544 · cited 2×
“…these findings encourage the view that such pharmacological treatments could one day serve to induce resident OPC differentiation and improve outcome in demyelinating diseases such as MS, where OL differentiation is impaired (Franklin and Kotter, 2008; Franklin and ffrench-Constant, 2008).”
BackgroundCell death and control of cell survival in the oligodendrocyte lineage
Barres, B. A., Hart, I. K., Coles, H. S. R., Burne, J. F., Voyvodic, J. T., Richardson, W. D., & Raff, M. C. (1992) · Cell · doi:10.1016/0092-8674(92)90531-g · Cited by 1,345 · cited 7×
“Like T3, GC-1 does not significantly affect PDGF-induced OPC proliferation.”
BackgroundInfluentialGur, R. C., Turetsky, B. I., Matsui, M., Yan, M., Bilker, W., Hughett, P., & Gur, R. E. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-10-04065.1999 · Cited by 909 · cited 4×
“WM volume (Gur et al., 1999), especially in the corpus callosum (Fitch et al., 1990) is increased in males, with females having more unmyelinated fibers.”
BackgroundInfluentialZhou, Q., Wang, S., & Anderson, D. J. (2000) · Neuron · doi:10.1016/s0896-6273(00)80898-3 · Cited by 789 · cited 2×
“Two basic helix-loop-helix transcription factors, Olig1 and Olig2, play essential roles in determining the oligodendroglial lineage and in the generation and maturation of OLs (Zhou et al., 2000; Lu et al., 2001).”
BackgroundMultiple extracellular signals are required for long-term oligodendrocyte survival
Barres, B. A., Schmid, R., Sendnter, M., & Raff, M. C. (1993) · Development · doi:10.1242/dev.118.1.283 · Cited by 712
Overview of nomenclature of nuclear receptors
Germain, P., Staels, B., Dacquet, C., Spedding, M., & Laudet, V. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.2 · Cited by 688 · cited 2×
“NRs modulate transcription through mechanisms which include both activation and repression (Germain et al., 2006b).”
BackgroundBalancing Plasticity/Stability Across Brain Development
Takesian, A. E., & Hensch, T. K. (2013) · Progress in Brain Research · doi:10.1016/b978-0-444-63327-9.00001-1 · Cited by 667 · cited 1×
“GABA is the main inhibitory neurotransmitter in adult brain (Koós and Tepper, 1999; Markram et al., 2004; Takesian and Hensch, 2013), where it binds two main receptor types: fast hyperpolarizing ionotropic GABAA receptors and metabotropic GABAB receptors.”
BackgroundMetabotropic glutamate receptors as novel targets for anxiety and stress disorders
Swanson, C. J., Bures, M., Johnson, M. P., Linden, A.-M., Monn, J. A., & Schoepp, D. D. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1630 · Cited by 607
Zoeller, R. T., & Rovet, J. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2004.01243.x · Cited by 605
Dicer1 and miR-219 Are Required for Normal Oligodendrocyte Differentiation and Myelination
Dugas, J. C., Cuellar, T. L., Scholze, A., Ason, B., Ibrahim, A., Emery, B., Zamanian, J. L., Foo, L. C., McManus, M. T., & Barres, B. A. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.027 · Cited by 577 · cited 1×
“OL differentiation can follow several distinct pathways, including mitogen withdrawal and exposure to T3 (Barres et al., 1993; Dugas et al., 2010), whereas OPC proliferation is induced by PDGF (Barres et al., 1992).”
BackgroundRetinoid X receptor gamma signaling accelerates CNS remyelination
Huang, J. K., Jarjour, A. A., Nait Oumesmar, B., Kerninon, C., Williams, A., Krezel, W., Kagechika, H., Bauer, J., Zhao, C., Evercooren, A. B.-V., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2702 · Cited by 547
A regenerative approach to the treatment of multiple sclerosis
Deshmukh, V. A., Tardif, V., Lyssiotis, C. A., Green, C. C., Kerman, B., Kim, H. J., Padmanabhan, K., Swoboda, J. G., Ahmad, I., Kondo, T., et al. (2013) · Nature · doi:10.1038/nature12647 · Cited by 531
International Union of Pharmacology. LXIII. Retinoid X receptors
Germain, P., Chambon, P., Eichele, G., Evans, R. M., Lazar, M. A., Leid, M., De Lera, A. R., Lotan, R., Mangelsdorf, D. J., & Gronemeyer, H. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.7 · Cited by 496
Rapid Conduction and the Evolution of Giant Axons and Myelinated Fibers
Hartline, D. K., & Colman, D. R. (2007) · Current Biology · doi:10.1016/j.cub.2006.11.042 · Cited by 478 · cited 1×
“A lipid-rich membrane, myelin (Virchow, 1854), insulates the axon and allows for rapid conduction of such impulses and proper delivery to the target cell (Hartline and Colman, 2007).”
BackgroundRemyelination in multiple sclerosis
Prineas, J. W., & Connell, F. (1979) · Annals of Neurology · doi:10.1002/ana.410050105 · Cited by 454
Aston, C., Jiang, L., & Sokolov, B. P. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001565 · Cited by 427
bHLH Transcription Factor Olig1 Is Required to Repair Demyelinated Lesions in the CNS
Arnett, H. A., Fancy, S. P. J., Alberta, J. A., Zhao, C., Plant, S. R., Kaing, S., Raine, C. S., Rowitch, D. H., Franklin, R. J. M., & Stiles, C. D. (2004) · Science · doi:10.1126/science.1103709 · Cited by 416
Synaptic vesicle release regulates myelin sheath number of individual oligodendrocytes in vivo
Mensch, S., Baraban, M., Almeida, R., Czopka, T., Ausborn, J., El Manira, A., & Lyons, D. A. (2015) · Nature Neuroscience · doi:10.1038/nn.3991 · Cited by 398
What is the real physiological NO concentration in vivo?
Hall, C. N., & Garthwaite, J. (2009) · Nitric Oxide · doi:10.1016/j.niox.2009.07.002 · Cited by 378 · cited 18×
“The central nervous system (CNS) relies on a network of neuronal cells to transmit electrical impulses known as action potentials along the axon.”
BackgroundInfluentialGlutamate receptor-mediated toxicity in optic nerve oligodendrocytes
Matute, C., Sánchez-Gómez, M. V., Martínez-Millán, L., & Miledi, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8830 · Cited by 352 · cited 2×
“Prolonged activation of GluRs is toxic to primary OLs in vitro and in vivo (Matute et al., 1997; McDonald et al., 1998; Li and Stys, 2000).”
BackgroundCalcaterra, S., Glanz, J., & Binswanger, I. A. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.11.018 · Cited by 330 · cited 1×
“The growing use/abuse of opioids among younger persons (Compton and Volkow, 2006; Calcaterra et al., 2013) poses an especially high risk to pregnant addicts (in whom drug effects could target early myelination in the fetus and newborn) and adolescents and young adults (in whom late myelination of…”
BackgroundSerotonin: a regulator of neuronal morphology and circuitry
Daubert, E. A., & Condron, B. G. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.05.005 · Cited by 326
Nopoulos, P., Flaum, M., O’Leary, D., & Andreasen, N. C. (2000) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(99)00044-x · Cited by 303
Multiple Sclerosis: Remyelination in Acute Lesions
Raine, C. S., & WU, E. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199305000-00003 · Cited by 285
Xing, Y. L., Röth, P. T., Stratton, J. A. S., Chuang, B. H. A., Danne, J., Ellis, S. L., Ng, S. W., Kilpatrick, T. J., & Merson, T. D. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3491-13.2014 · Cited by 275 · cited 1×
“Importantly, neural precursor cells have recently been demonstrated to make a major contribution to remyelination in the cuprizone model of CNS demyelination (Xing et al., 2014).”
BackgroundBenito, C., Romero, J. P., Tolón, R. M., Clemente, D., Docagne, F., Hillard, C. J., Guaza, C., & Romero, J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4814-06.2007 · Cited by 256
Wake, H., Ortiz, F. C., Woo, D. H., Lee, P. R., Angulo, M. C., & Fields, R. D. (2015) · Nature Communications · doi:10.1038/ncomms8844 · Cited by 244 · cited 1×
“There is also evidence that oligodendroglia exhibit Ca2+ transients in response to electrical activity of axons for activity-dependent myelination (Wake et al., 2015).”
BackgroundSynaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness
Honer, W. G., Falkai, P., Chen, C., Arango, V., Mann, J. J., & Dwork, A. J. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00679-4 · Cited by 244 · cited 2×
“Two basic helix-loop-helix transcription factors, Olig1 and Olig2, play essential roles in determining the oligodendroglial lineage and in the generation and maturation of OLs (Zhou et al., 2000; Lu et al., 2001).”
BackgroundTaylor, W. D., MacFall, J. R., Payne, M. E., McQuoid, D. R., Provenzale, J. M., Steffens, D. C., & Krishnan, K. R. R. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1293 · Cited by 230 · cited 2×
“Two basic helix-loop-helix transcription factors, Olig1 and Olig2, play essential roles in determining the oligodendroglial lineage and in the generation and maturation of OLs (Zhou et al., 2000; Lu et al., 2001).”
BackgroundLutfy, K., Eitan, S., Bryant, C. D., Yang, Y. C., Saliminejad, N., Walwyn, W., Kieffer, B. L., Takeshima, H., Carroll, F. I., Maidment, N. T., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10331.2003 · Cited by 211
The nuclear receptor superfamily: a personal retrospect on the first two decades
Chambon, P. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0125 · Cited by 194
Regenold, W. T., Phatak, P., Marano, C. M., Gearhart, L., Viens, C. H., & Hisley, K. C. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.12.019 · Cited by 178 · cited 2×
“Two basic helix-loop-helix transcription factors, Olig1 and Olig2, play essential roles in determining the oligodendroglial lineage and in the generation and maturation of OLs (Zhou et al., 2000; Lu et al., 2001).”
BackgroundLiver X receptors alpha and beta promote myelination and remyelination in the cerebellum
Meffre, D., Shackleford, G., Hichor, M., Gorgievski, V., Tzavara, E. T., Trousson, A., Ghoumari, A. M., Deboux, C., Nait Oumesmar, B., Liere, P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424951112 · Cited by 114 · cited 1×
“These data strongly support a new role for LXRs as positive modulators in central (re)myelination processes (Meffre et al., 2015).”
BackgroundMechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer’s disease
Lassmann, H. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0607-8 · Cited by 112
Progesterone treatment of spinal cord injury: effects on receptors, neurotrophins, and myelination
De Nicola, A. F., Gonzalez, S. L., Labombarda, F., Deniselle, M. C. G., Garay, L., Guennoun, R., & Schumacher, M. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:28:1:3 · Cited by 92 · cited 2×
“It is also possible that sex steroids could exert a protective effect onmyelin in developing, as well as injured WM (De Nicola et al., 2006; Gerstner et al., 2007; Garay et al., 2008).”
BackgroundEstradiol attenuates hyperoxia‐induced cell death in the developing white matter
Gerstner, B., Sifringer, M., Dzietko, M., Schüller, A., Lee, J., Simons, S., Obladen, M., Volpe, J. J., Rosenberg, P. A., & Felderhoff‐Mueser, U. (2007) · Annals of Neurology · doi:10.1002/ana.21118 · Cited by 85 · cited 1×
“It is also possible that sex steroids could exert a protective effect onmyelin in developing, as well as injured WM (De Nicola et al., 2006; Gerstner et al., 2007; Garay et al., 2008).”
BackgroundOligodendrocyte differentiation from adult multipotent stem cells is modulated by glutamate
Cavaliere, F., Urra, O., Alberdi, E., & Matute, C. (2012) · Cell Death & Disease · doi:10.1038/cddis.2011.144 · Cited by 69
Palumbo, S., Toscano, C. D., Parente, L., Weigert, R., & Bosetti, F. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07363.x · Cited by 46
Wang, J., Qiao, J., Zhang, Y., Wang, H., Zhu, S., Zhang, H., Hartle, K., Guo, H., Guo, W., He, J., et al. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12792 · Cited by 43 · cited 1×
“SSRIs (Loughhead et al., 2006) and serotonin/norepinephrine reuptake inhibitors (Wang et al., 2014), which are widely prescribed for major depression in pregnant women, are able to cross the placenta and reach fetal compartments.”
BackgroundCarlson, N. G., Hill, K. E., Tsunoda, I., Fujinami, R. S., & Rose, J. W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.01.008 · Cited by 42 · cited 1×
“COX-2 is expressed in dying OLs at the onset of demyelination in Theiler’s murine encephalomyelitis virus model of MS (Carlson et al., 2006) and in dying OLs in MS lesions (Carlson et al., 2010).”
BackgroundCarlson, N. G., Bellamkonda, S., Schmidt, L., Redd, J., Huecksteadt, T., Weber, L. M., Davis, E., Wood, B., Maruyama, T., & Rose, J. W. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0323-7 · Cited by 11
Cited by
An Inflammation-Centric View of Neurological Disease: Beyond the Neuron
Skaper, S. D., Facci, L., Zusso, M., & Giusti, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00072 · Cited by 457
Self-citationKlose, J., Pahl, M., Bartmann, K., Bendt, F., Blum, J., Dolde, X., Förster, N., Holzer, A.-K., Hübenthal, U., Keßel, H. E., et al. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-021-09603-2 · Cited by 58
“They have a high energy and iron demand, are dependent on functional lipid metabolism, and their development and function are highly regulated by different hormones and growth factors (Bradl and Lassmann 2010; Volpe et al. 2011; Marinelli et al. 2016).”
BackgroundScientific Validation of Human Neurosphere Assays for Developmental Neurotoxicity Evaluation
Koch, K., Bartmann, K., Hartmann, J., Kapr, J., Klose, J., Kuchovská, E., Pahl, M., Schlüppmann, K., Zühr, E., & Fritsche, E. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.816370 · Cited by 48
“While PDGFRA is predominantly a marker of immature OPCs, especially MBP is a myelin-associated gene increasingly expressed during oligodendrocyte maturation (Barateiro and Fernandes, 2014; Marinelli et al., 2016).”
BackgroundMironova, Y. A., Lenk, G. M., Lin, J.-P., Lee, S. J., Twiss, J. L., Vaccari, I., Bolino, A., Havton, L. A., Min, S. H., Abrams, C. S., et al. (2016) · eLife · doi:10.7554/elife.13023 · Cited by 35
Boccazzi, M., Macchiarulo, G., Lebon, S., Janowska, J., Le Charpentier, T., Faivre, V., Hua, J., Marangon, D., Lecca, D., Fumagalli, M., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106315 · Cited by 22
Metadata
- Authors
- Marinelli, C., Bertalot, T., Zusso, M., Skaper, S. D., & Giusti, P.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2016-02-12
- Volume
- 10
- Pages
- 27-27
- ISSN
- 1662-5102 (ISSN-L)
- OpenAlex
- W2285187319
- Cited by
- 87
- References
- 49
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.